CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 104.50
+3.00 (2.96%)
Sep 17, 2026, 1:59 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 21.72 billion as of September 17, 2026. Its market cap has increased by 160.26% in one year.
Market Cap
21.72B
Enterprise Value
19.77B
Revenue
1.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
104.50
ChartMarket Cap Chart
Since September 27, 2017, CHO Pharma's market cap has increased from 15.00B to 21.72B, an increase of 44.82%. That is a compound annual growth rate of 4.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 21.72B | 261.21% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.51B |
| Oneness Biotech | 20.86B |
| Medigen Vaccine Biologics | 19.63B |
| TaiMed Biologics | 16.28B |
| Ever Supreme Bio Technology | 15.66B |
| Gongwin Biopharm Holdings | 15.20B |
| EirGenix | 14.53B |
| ACRO Biomedical | 13.03B |